Document is current
Any future updates will be listed below
-
Authors
Gao, Zhen
Yang, Fei
Pan, Hong
Zhang, Lele
Li, Weiwang
Li, Ruonan
Zhao, Jingyu
Luo, Yuechen
Yu, Xiao
Kuang, Zhexiang
Nie, Neng
Li, Jianping
Huang, Jinbo
Zhao, Xin
Ge, Meili
Zheng, Yizhou
Fang, Liwei
Shi, Jun
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82300162)
National Natural Science Foundation of China (82270145)
National Key Research and Development Program of China (2024YFC2510500)
Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2022-I2M-2-003, 2021-I2M-1-073)
- License Information
-
More Information
Article History
Received: 14 February 2026
Accepted: 16 April 2026
First Online: 21 April 2026
Declarations
:
: This study utilizes data from the National Longitudinal Cohort of Hematological Diseases in China (NICHE, NCT04645199). The trial was conducted in compliance with the principles outlined in the Declaration of Helsinki and received approval from the ethics committees at the Institute of Hematology and Blood Diseases Hospital (approval no. IIT2021029-EC-1). Informed written consent was obtained from all participating patients.
: The authors declare no competing interests.
